Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Healthcare Services — General medicine - private practice. Per the activity note to the FY2021 annual report, the company operates a pediatric hospital. Founded on 16 July 2014; named after the pediatrician Ketevani Nemtsadze.
| Ratio | 2019 | 2020 | 2021 |
|---|---|---|---|
| Margins | |||
| Gross Margin | 94.4% | 94.8% | 96.3% |
| EBITDA Margin | 9.6% | -21.3% | 17.9% |
| EBITDAR | 314 | -199 | 607 |
| EBITDAR Margin | 14.6% | -14.6% | 22.3% |
| EBIT Margin | -0.6% | -37.6% | 15.7% |
| Net Profit Margin | -12.5% | -30.0% | 15.2% |
| Operating Expense % of Sales | 84.8% | 116.2% | 78.3% |
| Returns | |||
| Return on Assets (ROA) | -15.5% | -27.4% | 28.3% |
| Return on Equity (ROE) | N/A | N/A | N/A |
| ROIC [EBIT / Invested Capital] | -1.1% | -66.8% | 254.4% |
| Leverage & debt balances | |||
| Debt-to-Assets | 74.5% | 90.4% | 45.9% |
| Debt-to-Equity | -13.25x | -2.47x | -3.29x |
| Debt-to-EBITDA | 6.20x | N/A | 1.38x |
| Equity-to-Assets | -5.6% | -36.6% | -13.9% |
| Net Debt | 1,275 | 1,309 | 373 |
| Cash & Equivalents | 10 | 34 | 299 |
| Total Debt | 1,285 | 1,343 | 672 |
| Liquidity & working capital | |||
| Current Ratio | 1.32x | 0.96x | 1.17x |
| Quick Ratio | 1.14x | 0.81x | 1.11x |
| Cash Ratio | 0.02x | 0.05x | 0.30x |
| Total Current Assets | 707 | 661 | 1,168 |
| Total Current Liabilities | 537 | 686 | 998 |
| Inventory | 95 | 104 | 58 |
| Trade Receivables | 601 | 522 | 782 |
| Trade Payables | 392 | 496 | 768 |
| Net Working Capital | 169 | -25 | 171 |
| Net Working Capital % of Revenue | 7.9% | -1.8% | 6.3% |
| Trade Working Capital | 304 | 131 | 72 |
| Trade Working Capital % of Revenue | 14.2% | 9.7% | 2.6% |
| Change in Trade Working Capital | N/A | -173 | -59 |
| Turnover & efficiency | |||
| Inventory Turnover | 1.26x | 0.67x | 1.74x |
| Days Inventory Outstanding (DIO) | 289.1 | 542.7 | 209.7 |
| Receivables Turnover | 3.57x | 2.60x | 3.48x |
| Days Sales Outstanding (DSO) | 102.2 | 140.4 | 104.8 |
| Payables Turnover | 0.31x | 0.14x | 0.13x |
| Days Payable Outstanding (DPO) | 1195.1 | 2575.5 | 2766.6 |
| Cash Conversion Cycle | -803.9 days | -1892.4 days | -2452.1 days |
| Asset Turnover | 1.25x | 0.91x | 1.86x |
| Cash flow & dividends | |||
| Operating Cash Flow | 161 | 156 | 475 |
| Free Cash Flow (OCF − Capex proxy) | 169 | 182 | 440 |
| Cash Conversion (OCF / EBITDA) | 77.8% | N/A | 97.4% |
| Dividends Declared | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →